Colon Rectal CancerCCR-VINCatNCT04496635
Surveillance and Implementation of a Bundle of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat)
A study testing Implementation of a bundle of care in people with Colon Rectal Cancer and Surgical Site Infection, run by Hospital de Granollers at 1 site in Spain.
Trial summary
The Nosocomial Infection Surveillance Program in Catalonia (VINCat) monitors surgical site infection (SSI) in elective colorectal surgery since 2007 in 55 public and private acute care hospitals. These hospitals perform active and prospective standardized surveillance of elective colorectal resections. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Colon Rectal Cancer, Surgical Site Infection
- What is being tested?
- Implementation of a bundle of care
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60,000 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jan 2007to 30 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Colon or rectal elective surgery.
Who cannot join
- Peritonitis at the time of intervention ("dirty" surgery) Patients who underwent multiple procedures during the same surgery, for example resection of liver metastases Centers that performed less tan 10 surgical procedures annually Centers that have not been able to ensure prospective surveillance during hospitalization or effective monitoring of cases within 30 days of the intervention
Trial locations and contacts
1 site in 1 country.
Spain1 site, 1 recruiting
- Recruiting
Hospital General de Granollers
Granollers, Barcelona, 08402
Josep M Badia, 670702099, jmbadiaperez@gmail.com
About this study
Official title: Evaluation of the Application and Efficacy of Prevention Measures for Surgical Site Infection in Elective Colorectal Surgery.
The Nosocomial Infection Surveillance Program in Catalonia (VINCat) monitors surgical site infection (SSI) in elective colorectal surgery since 2007 in 55 public and private acute care hospitals. These hospitals perform active and prospective standardized surveillance of elective colorectal resections. Post-discharge surveillance is mandatory at least up to 30 days after surgery. Hospitals are classified according to their size into three groups: >500 hospital beds; 200-500 beds; <200 beds.
Aim. To examine the effect on SSI rate of a specific preventative bundle in elective colorectal surgery.
Read more
Methods. Pragmatic study using VINCat prospective colorectal database from 2007 to 2018. In 2016, a bundle of six preventative measures was recommended to the VINCat hospitals.
To compare the results of SSI before (baseline phase, BP) and after the bundle implementation (implementation phase, IP) a logistic regression model has been established. The results will be shown as Odds Ratio (OR) and the corresponding confidence intervalsCI95. The significance level will be fixed at 5% (P < 0.05).
Read the detailed description
Surveillance. The VINCat Program was developed in the 2007 as the Nosocomial Infection Surveillance system in Catalonia, covering a population of seven and a half million people. The system is similar to other international reference programs, such as the National Healthcare Safety Network (NHSN), and its described in detail on the VINCat website. Hospitals carry out active and prospective standardized surveillance, and are classified according to their number of beds into three groups: group 1 (500 beds); group 2 (200-500 beds); group 3 (200 beds). The staff performing surveillance had received training in the VINCat surveillance methodology to ensure the collection of homogeneous, accurate data.
Surveillance is continued at least for 30 days after the operation. All public and private participating hospitals report data voluntarily and receive feedback once a year.
Monitoring of colorectal surgery is performed prospectively and continued until a minimum of 100 interventions per year is reached in each hospital, although some centres include all their yearly cases. Hospitals with less than 10 interventions per year are excluded. Participating hospitals record the data on an Internet-based database.
Follow-up and post-discharge surveillance. Patients are followed up by trained infection control staff. Active mandatory post-discharge surveillance is performed at least to day 30 post surgery by a multimodal approach including electronic review of clinical records (primary and secondary care), checking readmissions, checking emergency visits, and reviewing microbiological and radiological data.
Development of the colorectal surgical site infection program. In 2015, a multidisciplinary team of nurses and medical specialists from the VINCat Program, and surgeons belonging to the Catalan Society of Surgery was set up to formulate a specific bundle of SSI preventative measures for colorectal surgery. The literature for optimal care during the preoperative, intraoperative and postoperative phases was reviewed, including evidence on oral antibiotic prophylaxis and mechanical bowel preparation. Practices were chosen either by their high levels of scientific evidence or by being considered, by consensus, reasonable, associated with minimal risk, and potentially beneficial.
The working group developed a 6 measures bundle to be voluntary implemented by the participating hospitals. The measures of the bundle are: intravenous and oral antibiotic prophylaxis, mechanical bowel preparation (MBP), laparoscopic surgery, maintenance of normothermia, and the use of a wound retractor.
The intervention began on 1 January 2016, with diffusion of the bundle measures via e-mail, and a workshop addressed to all to the surgical and ICT teams.
Definitions. SSI is defined according to the Centers for Disease Control (CDC) and is stratified into categories of surgical procedures (-1 to 3) according to the risk of surgical infection defined by the NHSN.
Design of the pragmatic trial. Implementation of the bundle precluded randomization. The study compared two phases: baseline (BP), from 2008 to 2015, and implementation (IP), from 2016 to 2018.
Fifty-five of the 66 hospitals participating in the VINCat Program were included in the analysis. Prospective surveillance was performed by the infection control team (ICT) of each hospital to ensure appropriate data collection. The surveillance period lasted from January 2007 to December 2018. During the first 4 years of the program, the results of colon and rectal surgery were aggregated. From 2011, data is separated for each type of surgery.
As all eligible patients were included in the pragmatic design, informed consent was not obtained.
The study was conducted as a performance improvement project and approved by the Ethics in Research Committee.
Statistical analysis Data will be summarized as frequencies and proportions for categorical variables or as medians and interquartile range (IQR) for continuous variables. Infection rates will be expressed as cumulative incidence, that is, the crude percentage of operations resulting in SSI/ number of surgery procedures. Data will be also stratified by year, risk index category, hospital group and SSI type.
To analyse the relationship between two qualitative variables, contingency tables will be used, and the chi-square test or the likelihood ratio test will be performed. The analysis will be completed with grouped bar graphs. To analyse differences in the proportion of infection over the years, the logistic regression model will be performed. The results will be presented in terms of OR or estimated infection rates, with the corresponding 95% confidence intervals. The significance level will be set at 5% in all tests. The results will be analysed using software: Statistical Analysis Systems (SAS) v9.4, SAS Institute Inc., Cary, USA.
- Conditions
- Colon Rectal Cancer, Surgical Site Infection
- Being tested
- Implementation of a bundle of care
- Keywords
- Surveillance, Preventative measures, Bundle of care, Colorectal surgery, Surgical site infection, Prevention
- Medical subject headings
- Colonic Neoplasms, Surgical Wound Infection
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Implementation of a bundle of careOther
| Study group | Role | What they receive |
|---|---|---|
| Baseline phase | No intervention | Patients included in the VINCat program, and operated on colorectal surgery between 2007 and 2015 in Catalonia |
| Implementation phase | Experimental | Patients included in the VINCat program, and operated on colorectal surgery between 2016 and 2018 in Catalonia Receives: Other: Implementation of a bundle of care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Surgical site infection rate
Overall surgical infection rate
Measured: 30 days
Secondary outcomes (3)
Organ/space surgical infection rate
Specific organ/space surgical infection rate
Measured: 30 days
Hospital type-Surgical infection rate
Comparison of rates among the three hospitals groups, according to their size
Measured: 30 days
Analysis (logistic regression model) of the efficacy of each preventive measure
Univariate and multivariate logistic regression to analise the efficacy of each individual measure belonging to the bundle of care.
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2020
- Study start1 Jan 2007
- Primary completion30 Nov 2025 (estimated)
- Study completion30 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colon Rectal CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Model description
- The study compare two phases: baseline (BP), from 2008 to 2015, and implementation (IP), from 2016 to 2018.
- Masking
- None (open label)
- Enrolment
- 60,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital de Granollers
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Josep M Badia-Perez, MD, PhD, Principal investigator, Fundació Hospital General de Granollers
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04496635
- Sponsor's protocol ID
- CCR-VINCat 1
- Acronym
- CCR-VINCat
- Status last verified
- Aug 2023
- First submitted
- 14 Jul 2020
- Last updated
- 22 Aug 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data will be shared when requested
Study at a glance
From the registry record, last updated by the sponsor on 22 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Application and Efficacy of Prevention Measures for Surgical Site Infection in Elective Colorectal Surgery.
- ClinicalTrials.gov ID
- NCT04496635
- Acronym / sponsor ID
- CCR-VINCat / CCR-VINCat 1
- Conditions
- Colon Rectal Cancer, Surgical Site Infection
- Keywords
- Surveillance, Preventative measures, Bundle of care, Colorectal surgery, Surgical site infection, Prevention
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60,000 participants (estimated)
- Lead sponsor
- Hospital de GranollersUniversity, hospital or other
- Study start
- 1 Jan 2007 (actual)
- Primary completion
- 30 Nov 2025 (estimated)
- Study completion
- 30 Dec 2025 (estimated)
- First posted
- 3 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Nosocomial Infection Surveillance Program in Catalonia (VINCat) monitors surgical site infection (SSI) in elective colorectal surgery since 2007 in 55 public and private acute care hospitals. These hospitals perform active and prospective standardized surveillance of elective colorectal resections. Post-discharge surveillance is mandatory at least up to 30 days after surgery. Hospitals are classified according to their size into three groups: >500 hospital beds; 200-500 beds; <200 beds.
Aim. To examine the effect on SSI rate of a specific preventative bundle in elective colorectal surgery.
Methods. Pragmatic study using VINCat prospective colorectal database from 2007 to 2018. In 2016, a bundle of six preventative measures was recommended to the VINCat hospitals.
To compare the results of SSI before (baseline phase, BP) and after the bundle implementation (implementation phase, IP) a logistic regression model has been established. The results will be shown as Odds Ratio (OR) and the corresponding confidence intervalsCI95. The significance level will be fixed at 5% (P < 0.05).
Detailed description
Surveillance. The VINCat Program was developed in the 2007 as the Nosocomial Infection Surveillance system in Catalonia, covering a population of seven and a half million people. The system is similar to other international reference programs, such as the National Healthcare Safety Network (NHSN), and its described in detail on the VINCat website. Hospitals carry out active and prospective standardized surveillance, and are classified according to their number of beds into three groups: group 1 (500 beds); group 2 (200-500 beds); group 3 (200 beds). The staff performing surveillance had received training in the VINCat surveillance methodology to ensure the collection of homogeneous, accurate data.
Surveillance is continued at least for 30 days after the operation. All public and private participating hospitals report data voluntarily and receive feedback once a year.
Monitoring of colorectal surgery is performed prospectively and continued until a minimum of 100 interventions per year is reached in each hospital, although some centres include all their yearly cases. Hospitals with less than 10 interventions per year are excluded. Participating hospitals record the data on an Internet-based database.
Follow-up and post-discharge surveillance. Patients are followed up by trained infection control staff. Active mandatory post-discharge surveillance is performed at least to day 30 post surgery by a multimodal approach including electronic review of clinical records (primary and secondary care), checking readmissions, checking emergency visits, and reviewing microbiological and radiological data.
Development of the colorectal surgical site infection program. In 2015, a multidisciplinary team of nurses and medical specialists from the VINCat Program, and surgeons belonging to the Catalan Society of Surgery was set up to formulate a specific bundle of SSI preventative measures for colorectal surgery. The literature for optimal care during the preoperative, intraoperative and postoperative phases was reviewed, including evidence on oral antibiotic prophylaxis and mechanical bowel preparation. Practices were chosen either by their high levels of scientific evidence or by being considered, by consensus, reasonable, associated with minimal risk, and potentially beneficial.
The working group developed a 6 measures bundle to be voluntary implemented by the participating hospitals. The measures of the bundle are: intravenous and oral antibiotic prophylaxis, mechanical bowel preparation (MBP), laparoscopic surgery, maintenance of normothermia, and the use of a wound retractor.
The intervention began on 1 January 2016, with diffusion of the bundle measures via e-mail, and a workshop addressed to all to the surgical and ICT teams.
Definitions. SSI is defined according to the Centers for Disease Control (CDC) and is stratified into categories of surgical procedures (-1 to 3) according to the risk of surgical infection defined by the NHSN.
Design of the pragmatic trial. Implementation of the bundle precluded randomization. The study compared two phases: baseline (BP), from 2008 to 2015, and implementation (IP), from 2016 to 2018.
Fifty-five of the 66 hospitals participating in the VINCat Program were included in the analysis. Prospective surveillance was performed by the infection control team (ICT) of each hospital to ensure appropriate data collection. The surveillance period lasted from January 2007 to December 2018. During the first 4 years of the program, the results of colon and rectal surgery were aggregated. From 2011, data is separated for each type of surgery.
As all eligible patients were included in the pragmatic design, informed consent was not obtained.
The study was conducted as a performance improvement project and approved by the Ethics in Research Committee.
Statistical analysis Data will be summarized as frequencies and proportions for categorical variables or as medians and interquartile range (IQR) for continuous variables. Infection rates will be expressed as cumulative incidence, that is, the crude percentage of operations resulting in SSI/ number of surgery procedures. Data will be also stratified by year, risk index category, hospital group and SSI type.
To analyse the relationship between two qualitative variables, contingency tables will be used, and the chi-square test or the likelihood ratio test will be performed. The analysis will be completed with grouped bar graphs. To analyse differences in the proportion of infection over the years, the logistic regression model will be performed. The results will be presented in terms of OR or estimated infection rates, with the corresponding 95% confidence intervals. The significance level will be set at 5% in all tests. The results will be analysed using software: Statistical Analysis Systems (SAS) v9.4, SAS Institute Inc., Cary, USA.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The study compare two phases: baseline (BP), from 2008 to 2015, and implementation (IP), from 2016 to 2018.
| Arm | Type | Receives |
|---|---|---|
| Baseline phase | No intervention | –Patients included in the VINCat program, and operated on colorectal surgery between 2007 and 2015 in Catalonia |
| Implementation phase | Experimental | Other: Implementation of a bundle of carePatients included in the VINCat program, and operated on colorectal surgery between 2016 and 2018 in Catalonia |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Colon or rectal elective surgery.
Key exclusion criteria (1 listed)
- Peritonitis at the time of intervention ("dirty" surgery) Patients who underwent multiple procedures during the same surgery, for example resection of liver metastases Centers that performed less tan 10 surgical procedures annually Centers that have not been able to ensure prospective surveillance during hospitalization or effective monitoring of cases within 30 days of the intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Implementation of a bundle of care | Other | Implementation phase |
Primary outcome
Surgical site infection rate
Time frame: 30 days
Overall surgical infection rate
3 secondary outcomes
Organ/space surgical infection rate
Time frame: 30 days
Hospital type-Surgical infection rate
Time frame: 30 days
Analysis (logistic regression model) of the efficacy of each preventive measure
Time frame: 30 days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Aug 2023.
- Individual participant dataSharing planned: No. Data will be shared when requested
Related trials for Colon Rectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Josep M Badia-Perez, MD, PhD principal investigator
Fundació Hospital General de Granollers
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Implementation of a bundle of care in people with Colon Rectal Cancer and Surgical Site Infection, run by Hospital de Granollers at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Gemma Molist, MD, PHD (+348425000, gmolist@fphag.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Surgical site infection rate (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2023.